Results from an ongoing clinical study conducted by Scripps Clinic indicate that MindMics' non-invasive IH technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles
December 26, 2023
MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs
December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new…
Read More
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation
December 26, 2023
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Catheter
December 26, 2023 — Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX…
Read More
The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and prosperous New Year!
December 25, 2023
Happy Holidays from the Diagnostic and Interventional Cardiology Team
The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and prosperous New Year…
Read More
Company appoints Mohammad Shokoohi-Yekta to lead program and industry pioneer Lance Myers as advisor
December 22, 2023
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
December 22, 2023 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the…
Read More
Study will evaluate investigational Dual Energy Thermocool SmartTouch SF Catheter potential to deliver safe and effective radiofrequency (RF) and pulsed field ablation (PFA)   
December 22, 2023
Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation
December 22, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.
December 22, 2023
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker
December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of…
Read More
Staten Island University Hospital (SIUH), part of Northwell Health, proudly announces its inclusion among the select few hospitals in Northwell Health to achieve the coveted three-star overall quality ratings by the Society of Thoracic Surgeons (STS) for its outstanding cardiothoracic surgery program
December 20, 2023
Staten Island University Hospital's Cardiothoracic Program Achieves Prestigious STS Three-Star Quality Ratings
December 20, 2023 — Staten Island University Hospital (SIUH), part of Northwell Health, proudly announces its inclusion…
Read More
Experts at the Smidt Heart Institute's new Aortic Surveillance Clinic will monitor patients with aortic aneurysms (illustrated here) or enlarged aortas. Image by Getty.
December 20, 2023
Smidt Heart Institute Opens Aortic Surveillance Clinic
December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the…
Read More
Jason McCarthy, Ph.D., associate professor of biomedical research and translational medicine at MMRI
December 20, 2023
MMRI Publishes Breakthrough Study Detailing a Novel Approach to Minimize Damage After a Heart Attack
December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and…
Read More
ECGI vest developed at UCL being worn by a UCL medical student
December 19, 2023
Heart Vest Could Help Predict Sudden Cardiac Death Risk
December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used…
Read More
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced that the first patient was enrolled and treated in its CardiALLO Allogeneic Mesenchymal Cell Therapy Phase I/II trial
December 19, 2023
BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction
December 19, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
Embedded AI and user assistance features of the Siemens Healthineers Somatom, which has received FDA clearance, deliver workflow efficiencies, according to a company statement.
December 19, 2023
Siemens Healthineers Announces FDA Clearance of Somatom Pro.Pulse Dual-Source CT Scanner
December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro.…
Read More
December 19, 2023
Clinical Trial Results from Peerbridge Health Unveil Direct-from-ECG Sleep Apnea Detection Using COR Wearable Platform
December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective,…
Read More
Smidt Heart Institute investigators develop algorithm that uses electrocardiograms to risk-stratify patients, prescribe appropriate treatment
December 18, 2023
New Artificial Intelligence Tool Predicts Mortality After Heart Surgeries
December 18, 2023 — An artificial intelligence (AI) tool developed by investigators at  the Smidt Heart Institute at…
Read More
Rating measures quality, safety, and outcomes of the five most common heart procedures
December 18, 2023
Cardiovascular Surgery at the Mount Sinai Hospital Wins Highest Quality National Ratings from Society of Thoracic Surgeons
December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest…
Read More
Substance use disorder may be linked to more deaths from infective endocarditis among people ages 25-44, finds new study in Journal of the American Heart Association
December 18, 2023
Deaths from Heart Valve Infections Drop Across US Overall, but Surged Among Young Adults
December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the…
Read More
Medtronic plc, a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF).
December 14, 2023
Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation
December 14, 2023 — Medtronic plc, a global leader in healthcare technology, today announced that the United States…
Read More
Henry Ford Health's National Cardiogenic Shock Initiative research team.
December 14, 2023
National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival
December 14, 2023 — Published results of a large, national heart attack study show that patients with a life-…
Read More
Ioannis Katsoularis
December 14, 2023
Increased Risk of Heart Rhythm Disruption After COVID-19
December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm…
Read More
New research sheds light on physician motivations, concerns, requirements and uses of AI
December 14, 2023
AMA: Physicians Enthusiastic but Cautious About Healthcare AI
December 14, 2023 — Physicians are enthusiastic about augmented intelligence (AI) - often called artificial…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now